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Available online 29 November 2016Background: Previous reports have shown that lipoprotein lipase (LPL) activity signiﬁcantly increases in the post-
prandial plasma associated with the increase of TG-rich lipoproteins. Therefore, we have reexamined those rela-
tionships using newly developed LPL assay with the different kinds of food intake.
Methods: Standard meal (n= 81), 50 g of fat (n= 54), 75 g of glucose (n= 25) and cookie (25 g fat and 75 g
carbohydrate fat) (n = 28) were administered in generally healthy volunteers. Plasma LPL, HTGL and TC, TG,
LDL-C, HDL-C, RLP-C and RLP-TG were determined at subsequent withdrawal after the food intake.
Results: Plasma TG, RLP-C and RLP-TG were signiﬁcantly increased at 8 PM (2 h after dinner of standard meal)
compared with 8 AM before breakfast within the same day. Also those parameters were signiﬁcantly increased
in 2–6 h after fat load. However, the concentrations and activities of LPL and HTGL did not signiﬁcantly increase
in association with an increase in the TG and remnant lipoproteins. Also LPL concentration did not signiﬁcantly
increase after glucose and “cookie test” within 4 h.
Conclusion:No signiﬁcant increase of LPL activitywas found at CM and VLDL overload after different kinds of food
intake when reexamined by newly developed assay for LPL activity and concentration.








Hepatic triglyceride lipase1. Introduction
Lipoprotein lipase (LPL) is a key enzyme for the hydrolysis of TG-rich
lipoproteinswhich are known to increase signiﬁcantly in diabetes, met-
abolic syndrome and cardiovascular diseases. As plasma triglycerides
(TG) are known to be a surrogate for TG-rich lipoproteins and are pres-
ent in chylomicrons (CM), very low density lipoproteins (VLDL) and
their remnants. TRL and their remnants are signiﬁcantly increased in
the postprandial plasma and are known to predict the risk of coronary
heart disease (CHD) and type 2 diabetes [1,2], independent of the
total cholesterol, LDL or HDL cholesterol level. In particular, the habitLaboratory Medicine, Gunma
achi, Maebashi, Gunma, Japan.
.of eating in diabetes patients and CHD patients is known to be deeply
associated with the increase of remnant lipoproteins. Recently, plasma
non-fasting TG levels have received attention as a signiﬁcant risk factor
for CHD events [3–5]. Zilversmit [6] ﬁrst proposed that the postprandial
CM is the most common risk factor for atherogenesis in the absence of
familial hyperlipoproteinemia. The hypothesis of postprandial CM and
CM remnants thus came to bewidely accepted as amajor cause of com-
mon atherogenesis, because it was well established that CM are signiﬁ-
cantly increased in the intestine after food intake, especially fat intake,
and a large amount ﬂows into the blood stream through the thoracic
duct. Therefore, CM and CM remnants have been believed to be the
major lipoproteins in the postprandial hyperlipidemia until recently.
However, Nakajima et al. [7] and Schneeman et al. [8] showed that the
major lipoproteins increased in the postprandial plasma are apoB100-
carrying VLDL remnants, but not apoB48-carrying CM remnants. The
Table 1
Comparison of pre-heparin LPL concentration between fasting and postprandial plasma
(mean ± SD).
Fasting (n = 79) Postprandial (n = 80) p value
TC (mg/dL) 165.8 ± 29.8 167.7 ± 27.9 n.s.
TG (mg/dL) 79.8 ± 41.6 128.2 ± 84.6 p b 0.001
HDL-C (mg/dL) 51.4 ± 13.2 50.1 ± 13.2 n.s.
LDL-C (mg/dL) 92.8 ± 27.0 93.2 ± 24.3 n.s.
sd-LDL (mg/dL) 26.5 ± 12.3 29.2 ± 13.2 n.s.
RLP-C (mg/dL) 4.2 ± 2.4 6.4 ± 4.5 p b 0.001
RLP-TG (mg/dL) 11.8 ± 15.1 52.1 ± 46.3 p b 0.001
RLP-TG/RLP-C 2.7 ± 1.6 8.1 ± 3.7 p b 0.001
LPL (ng/mL) 48.2 ± 7.6 43.5 ± 8.3 p b 0.001
Table 2
Comparison of post-heparin LPL and HTGL activity and concentration between fasting and
postprandial plasma (mean ± SD).
Fasting (n = 76) Postprandial (n = 81) p value
TC (mg/dL) 162.0 ± 29.8 163.8 ± 27.1 n.s.
TG (mg/dL) 58.1 ± 38.1 89.8 ± 70.4 p = 0.001
HDL-C (mg/dL) 50.0 ± 12.9 48.6 ± 12.8 n.s.
LDL-C (mg/dL) 91.3 ± 26.9 92.3 ± 24.0 n.s.
sd-LDL (mg/dL) 26.0 ± 12.5 28.6 ± 13.1 n.s.
RLP-C (mg/dL) 3.9 ± 2.0 5.7 ± 3.6 p b 0.001
RLP-TG (mg/dL) 6.9 ± 11.5 26.0 ± 35.0 p b 0.001
RLP-TG/RLP-C 1.6 ± 1.2 3.9 ± 2.6 p b 0.001
LPL (U/L) 79.6 ± 19.0 69.0 ± 16.1 p b 0.001
LPL (ng/mL) 216.6 ± 55.0 209.9 ± 45.1 n.s.
HTGL (U/L) 224.0 ± 92.8 202.9 ± 82.1 n.s.
HTGL (ng/mL) 166.7 ± 121.7 194.3 ± 116.2 n.s.
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pendent on LPL activity, but it remains controversial whether the circu-
lating LPL activity and concentration in plasma increase in association
with the increase of TG-rich lipoproteins after food intake.
The metabolism of TG-rich lipoproteins in human plasma provides
an energy-rich substrate for either immediate use in tissues or storage
as adipose tissue. However, in this process, potentially atherogenic lipo-
protein particles (remnants) are also generated by the function of LPL
activity. Lipolysis of triglycerides from CM and VLDL is catalyzedmainly
by LPL. Karpe [9] hypothesized that there is a competition for the lipol-
ysis induced by LPL between CM and VLDL after fat intake. They report-
ed that LPL hydrolyzes CMmore efﬁciently than VLDL. LPL binds to the
vascular endothelium because of it afﬁnity for heparan sulfate and GPI-
HBP1 [10], and low levels of LPL are released into the circulation after
the hydrolysis of CM and VLDL [11,12]. The binding of LPL to the endo-
thelium is thought to be weakened by the local fatty acid accumulation
that results from the lipolysis and release into the circulation after food
intake. This has been demonstrated in individuals in whom the lipolytic
system was overloaded by an infusion of triglyceride emulsions [12,13]
and also in cell culture experiments [14]. An excess of free fatty acids
(FFA) released from TG-rich lipoproteins after food intake has therefore
been proposed to exert feed-back control lipolysis and thus affect the
release of LPL into the circulation. We investigated the factors that gov-
ern the release of LPL into the circulation and whether evidence for the
proposed fatty acid feed-back control or similar system was obtainable
under physiological conditions in humans. We studied this by examin-
ing the postprandial LPL activity and concentration in the fasting and
postprandial plasma together with the associated lipid and lipoprotein
concentrations in individuals subjected to a standardmeal and other ar-
tiﬁcial food intake, such as fat load and sugar intake. As plasma LPL is
known to be an important diagnostic marker for lipid metabolism in di-
abetes and cardiovascular diseases, those food loading tests likeOGTT as
a diagnostic tool may be necessary in non-heparin plasma.
The biggest reason for the controversy over whether LPL activity in-
creases or not after fat intake is due to the fact that it is not possible to
determine LPL activity time-dependently within a short period of time
such as 1 or 2 h intervals after heparin administration. The effect of hep-
arin on the release of LPL from the endothelium remains over a period of
a few hours [15]. Therefore, the previous studies on the release of LPL
from endothelium after food intake were conducted in the non-heparin
plasma using a radiochemical LPL activity assay [11–13]. Because there
was no clinically useful, sensitive and speciﬁc LPL immunoassay around
1990, a low LPL concentration in non-heparin plasmawas difﬁcult to be
determined precisely. In this study, we selected volunteers who had a
wide range of basal plasma TG concentrations but generally healthy.
This provided an opportunity to identify the associations between the
plasma LPL activity and concentration with the diagnostic markers for
the metabolism of TG-rich lipoproteins. In particular, we paid attention
to the relationship between LPL activity and the formation of large RLP
particles released into circulation after different kind of food intake,
using a recently developed highly sensitive and speciﬁc LPL-ELISA and
activity assay in non- and post-heparin LPL plasma.
2. Materials and methods
2.1. Study subjects
The fasting and postprandial comparative study recruited relatively
healthy young volunteers (some cases were overweight or obese) in a
male (n = 41) and female (n = 40) population (Caucasian 45, Asian
10, Hispanic 9, African American 7, others 10) with a median age of 24
and BMI of 24 at the University of California, Davis (Tables 1 and 2).
The inclusion criteria were an age from 18 to 40 y and BMI of 18–
35 kg/m2, along with a self-report of stable body weight during the
prior 6 months. Exclusion criteria included evidence of diabetes, renal
disease, or hepatic disease; fasting serum TG concentrationsN400 mg/dL and hypertension (N140/90 mm Hg). Eighty one volun-
teers were injected with heparin (50 unit/kg) for the LPL and HTGL ac-
tivity assays. The University of California at Davis Institutional Review
Board approved the experimental protocol and the subjects provided
written informed consent to participate in the study. Baseline blood
samples of the fructose and glucose levels reported by Stanhope et al.
[16] were provided for this study, and all of the parameter analyses
were performed at Gunma University. Fasting blood samples were col-
lected before breakfast at 08:00 h and the postprandial blood samples
were collected after dinner at 20:00 h on the same day. During the
day, standardizedmeals [17]were provided at breakfast, lunch and din-
ner to all of the volunteers.
Fifty four volunteers for the oral fat load test without any cardiovas-
cular disease, diabetes or other distinctly evident conditions (male 30
and female 24, aged 28–63 y) were recruited at the Graduate School
of Health Sciences at Gunma University. Brieﬂy, after 12 h fasting, the
subjects ingested the equivalent of 17 g/m2 body surface area of fat
emulsion (OFTT cream, Jomo Foods) [18]. Blood sampleswere taken be-
fore and 60, 120, 240 and 360 min after the oral fat load.
Twenty ﬁve healthy males aged 50 to 79 without any speciﬁc dis-
eases or drug treatment were recruited for the glucose and sugar test
(OGTT) and the subjects provided written informed consent to partici-
pate in the study at Hidaka Hospital, Takasaki. The volunteers were
treated with 50 g of glucose and 50 g of sucrose, respectively, with
water as a control. Blood was withdrawn before and 15, 30, 60,
240 min after the treatment.
Twenty seven healthy volunteers (male 19 and female 8, aged 53±
11, BMI 24.6 ± 2.5) were recruited for the cookie test (25 g fat and 75 g
carbohydrate) [19] and blood was withdrawn at 0, 1, 2 and 4 h. The
studywas approved by the Ethical Committees of KyotoMedical Center
and the volunteers provided written informed consent to participate in
this study.
(We have performed fat load test in 84 patients with CHD with the
samemanner of ﬁfty four volunteers above at ShowaUniversity ofMed-
ical School, but the results are going to be reported at a separate
manuscript).
Fig. 1. Correlation between fasting and postprandial LPL concentration in pre-heparin plasma.
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tivity and concentration
The plasma samples used for the measurement of TC, TG, HDL-C,
LDL-C, RLP-C, RLP-TG and sdLDL-C were withdrawn before and after
heparin infusion and kept frozen at−80 °C until analysis. As the LPL
and HTGL activities were undetectable in the pre-heparin plasma, all
the lipase activities in this study were determined in the post-heparin
plasma. The post-heparin plasma was withdrawn 15 min after intrave-
nous injection of 50 units of heparin/kg bodyweight (BW) for the assay
of LPL along with the HTGL activity and concentration. The pre-heparin
LPL and HTGLmasswere determinedwith a highly sensitive and specif-
ic ELISA [20,21]. The LPL and HTGL activities were determined with the
automated assay [22]. Plasma samples were kept frozen at−80 °C until
analysis. The TC and TG concentrationswere determined enzymatically.
The LDL-C and HDL-C concentrations were measured using a homoge-
nous method (Kyowa Medex). Glucose and insulin were determined
using PolyChem (Polymedco). RLP-C and RLP-TG were determined with
an immunoseparation method (JIMRO II, Otsuka) [23,24]. Small dense
LDL-C was determined by the method of Ito et al. (Denka-Seiken) [25].
2.3. The sandwich LPL-ELISA procedure
The LPL plasma concentration was measured using a novel LPL-
ELISA developed at Immuno-Biological Laboratories (IBL) [26]. This isFig. 2. Correlation between fasting and postprandial LPL activity (A) and faa solid phase sandwich ELISA using 2 kinds of highly speciﬁc monoclo-
nal antibodies against human recombinant LPL. The assay used two dif-
ferent monoclonal antibodies against human recombinant LPL for the
sandwich ELISA, which has the capacity to detect both monomeric and
dimeric LPL. Tetra methyl benzidine (TMB) was used as the coloring
agent (Chromogen). The strength of the coloring observed is propor-
tional to the quantity of human recombinant LPL. Brieﬂy, 100 μL of plas-
ma or standard LPL diluted N100-fold was incubated with a solid phase
antibody (57A5) for 60 min at 37 °C using a plate lid. After washing the
plate with phosphate buffer, another antibody (88B8) labeled with
horse radish peroxidase was added and incubated for 30 min at 4 °C
with the plate lid. After washing, chromogen was added and incubated
for 30min at room temperature. The plate was read at 450 nm against a
reagent blankwithin 30min of the addition of 1mol/L H2SO4 solution to
stop the reaction. Themeasurement range of the assaywas shown to be
0.02–1.5 ng/mL. The coefﬁcient of variation was b10% in both the intra-
and inter-assays.2.4. LPL activity assay
The LPL andHTGL activitieswere determined by an automated activ-
ity assay [22] for measuring the increase in absorbance at 546 nm by
means of a quinoneine dye. Reaction mixture-1 (R-1) contained
dioleoylglycerol solubilized with lauryldimethylaminobetaine,
monoacylglycerol-speciﬁc lipase, glycerolkinase, glycerol-3-phosphate
oxidase, peroxidase, ascorbic acid oxidase and apolipoprotein C-II
(apoC-II). R-2 contained Tris-HCl (pH 8.7) and 4-aminoantipyrine. Au-
tomated assay of the lipase activity was performed with an automatic
clinical analyzer (H7700P). In the assay for HTGL and LPL activity,
160 μL of R-1 was incubated at 37 °C with 2 μL of plasma sample for
5 min, then 80 μL of R-2 was added. LPL activity was calculated from
the total lipase activity by subtracting the HL activity measured under
the same conditions without apoC-II.2.5. Statistical analysis
Data were analyzed with Dr. SPSS II. Quantitative variables are
reported as the mean ± SD values. The statistical signiﬁcance of
difference was determined with the Mann-Whitney U test. The
correlation between variables is presented as Pearson's correlation
coefﬁcient (r = value). p b 0.05 was considered statistically
signiﬁcant.sting and postprandial LPL concentration (B) in post-heparin plasma.
Fig. 3. Correlation between fasting and postprandial HTGL activity (A) and fasting and postprandial HTGL concentration (B) in post-heparin plasma.
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3.1. Effect of a standard meal on the LPL and HTGL concentrations and ac-
tivities as well as plasma lipids and lipoproteins in the pre-heparin and
post-heparin plasma
The fasting as well as postprandial plasma levels of lipids and lipo-
proteins in the pre-heparin and post-heparin plasma in 81 volunteers
are shown in Tables 1 and 2. The mean total cholesterol (TC), LDL-C,
sdLDL-C and HDL-C levels were within the normal range and did not
change between the fasting (8 AM) and postprandial (8 PM) plasma.
TG, RLP-C, RLP-TG and the RLP-TG/RLP-C ratio were signiﬁcantly elevat-
ed in the postprandial state in both the pre-heparin and post-heparin
plasma. As the LPL and HTGL activities were undetectable in the non-
heparin plasma, only the LPL concentration was determined (Table 1),
while the LPL and HTGL activities and concentrations were both deter-
mined in the post-heparin plasma (Table 2).
The LPL activity and concentration were found to be slightly de-
creased in the postprandial plasma compared with the fasting plasma,
with signiﬁcantly elevated TG and remnant lipoproteins. However, the
HTGL activity and concentration were unchanged in the postprandial
plasma (Table 2).
As shown in Fig. 1, the fasting pre-heparin LPL concentration and
postprandial pre-heparin LPL concentration were positively correlated
(r2=0.334, p b 0.001), and the fasting LPL levelwas slightly, but not sig-
niﬁcantly higher in the postprandial plasma than in the pre-heparin
plasma, although TG-rich lipoproteins were signiﬁcantly elevated in
the postprandial plasma.
Fig. 2 shows the weak but positive correlation between the
fasting post-heparin LPL activity and postprandial post-heparin LPLTable 3
The changes of plasma lipids, lipoproteins and LPL concentration after fat load (mean ± SD).
0 h 2 h
TC (mg/dL) 207.7 ± 29.4 210.1 ± 3
TG (mg/dL) 99.8 ± 55.9 161.6 ± 7
HDL-C (mg/dL) 67.0 ± 17.1 66.5 ± 17
LDL-C (mg/dL) 123.6 ± 27.2 122.8 ± 2
RLP-C (mg/dL) 5.1 ± 2.4 7.4 ± 3.1⁎
RLP-TG (mg/dL) 14.8 ± 15.1 67.3 ± 43
RLP-TG/RLP-C 2.6 ± 1.6 8.9 ± 3.3⁎
LPL (ng/mL) 62.3 ± 45.7 65.5 ± 37
0 h vs 2 h, 4 h, and 6 h by U test.
⁎ p b 0.05.activity (Fig. 2A) (r2 = 0.054, p=0.043), while the fasting post-hep-
arin LPL concentration was more strongly correlated with the post-
prandial post-heparin LPL concentration (r2 = 0.218, p b 0.001)
(Fig. 2B).
The HTGL activity (Fig. 3A) and concentration (Fig. 3B) were also
correlated between the fasting and postprandial post-heparin plas-
ma (r2 = 0.078, p = 0.014: r2 = 0.139, p = 0.006). Those results
showed that there were no signiﬁcant increase of LPL and HTGL ac-
tivity and concentration in the postprandial plasma compare to the
fasting plasma.3.2. Effect of oral fat load on the LPL concentration in the pre-heparin plas-
ma of healthy volunteers
The serum TG concentrations increased 2-fold 4 h after an oral fat
load, while RLP-TG increased 7-fold, as shown in Table 3. Therefore,
the RLP-TG/total TG ratio increased signiﬁcantly from 12% (0 h) to 46%
in 4 h (3.8-fold). The increase in RLP-C in the postprandial plasma was
b2 fold and the RLP-C/total TG ratio was only 5,1% in the fasting state,
and decreased slightly at 4 h (4.4%) in the postprandial state. The RLP-
TG/RLP-C ratio, which is indicative of the RLP particle size [27], in-
creased 4.6-fold 4 h after the oral fat load, which means that the RLP
particles released into circulation after hydrolysis of TG-rich lipopro-
teins on endothelium were signiﬁcantly larger (i.e. were more TG-
rich) than the fasting RLP particles. Table 3 also shows that N80% of
the increased TG (ΔTG) after an oral fat load was derived from the in-
creased RLP-TG (ΔRLP-TG) and kept increasing in for 2 to 6 h in the
postprandial state. However, the LPL concentration did not increase in
association with the increase in TG and remnant lipoproteins (Fig. 4).4 h 6 h
4.2 209.5 ± 31.4 209.1 ± 29.3
4.1⁎ 208.2 ± 115.1⁎ 157.4 ± 111.8⁎
.4 64.6 ± 17.0 65.0 ± 16.5
9.2 120.0 ± 27.1 121.4 ± 26.3
9.1 ± 4.8 8.1 ± 5.8⁎
.9⁎ 107.1 ± 84.6⁎ 64.1 ± 71.1⁎
11.0 ± 4.7⁎ 6.9 ± 3.4⁎
.5 66.9 ± 42.6 81.2 ± 53.1
Fig. 4. The changes of plasma TG, RLP-TG and LPL at 0h, 2h, 4h and 6h after fat load.
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Two kinds of carbohydrate (glucose and sucrose)were administered
to the volunteers, withwater as the control (Table 4). Blood glucose and
insulin (IRI) levels were signiﬁcantly increased in 30 min, but the LPL
concentration did not change (Fig. 5). LPL activity was undetectable
30 and 60 min after carbohydrate intake in the pre-heparin plasma.
The TG and remnant lipoprotein levels were unchanged after the glu-
cose and sugar treatment.
3.4. Effect of an oral fat and sugar combination load on the LPL
concentration
The “cookie” contained both fat and sugar. Therefore, the blood
sugar and TG levels increased signiﬁcantly after treatment in all cases
(Table 5). However, the LPL concentration did not change signiﬁcantly
in the pre-heparin plasma.
4. Discussion
Recently LPL has been paidmore attention to the clinical signiﬁcance
of measuring this parameter in non-heparin plasma in more common
metabolic disorders such as diabetes and metabolic syndrome than of
rare LPL deﬁciency [28]. Studies have shown that low LPL activity and
concentration has signiﬁcant relationships with elevated serum lipids
and lipoproteins, visceral fat area, insulin resistance, and even the devel-
opment of coronary atherosclerosis [28]. Furthermore, a prospective
study has demonstrated that low LPL concentration predicts future cor-
onary events in prenon-heparin plasma in non-heparin plasma-heparin
plasma [29]
The present study investigated the regulation of the plasma LPL ac-
tivity and concentration after food intake in generally healthy volun-
teers. Although we found the similar results in patients with CHD and
diabetes, we have focused on the results of healthy subjects under the
physiological condition. In particular, the aim of this study was to reex-
amine whether the LPL activity and concentration increases along withTable 4
The changes of plasma lipids, lipoproteins, insulin and LPL concentration after glucose ant sucr
Water (n = 6) Glucos
Before 120 min Before
TC (mg/dL) 219.5 ± 38.5 211.3 ± 35.5 200.3 ±
TG (mg/dL) 184.0 ± 123.6 134.8 ± 48.1 91.7 ±
LDL-C (mg/dL) 135.0 ± 39.9 133.6 ± 36.6 119.6 ±
RLP-C (mg/dL) 5.7 ± 2.9 7.7 ± 5.3 5.1 ± 2
RLP-TG (mg/dL) 23.7 ± 16.7 23.8 ± 13.7 16.3 ±
IRI (μU/ｍL) 6.3 ± 1.9 4.4 ± 2.3 5.9 ± 2
LPL (ng/mL) 67.1 ± 17.7 72.0 ± 19.5 61.4 ±the increase in TG-rich lipoproteins after food intake using a newly de-
veloped LPL assay methods. The experimental results showed a sub-
stantial increase in plasma triglycerides after food intake. Previous
studies have reported that LPL activity in the non-heparin plasma signif-
icantly increased after an oral fat load and the increase in LPL activity oc-
curred in parallel with the postprandial FFA response derived directly
from chylomicrons [13,30]. Two parameters that might be causally re-
lated are the rise in plasma triglycerides [11], since LPL is known to
bind to TG-rich lipoproteins [31–33], and recirculation in the plasma
of the unesteriﬁed fatty acids derived from hydrolysis of the lipoprotein
triglycerides [12], since there is evidence that fatty acids can dissociate
LPL from its binding sites [13,14]. FFA was the parameter that showed
the strongest association with LPL. Furthermore, an 18:2 FFA correlated
with LPL, whereas there was no signiﬁcant correlation between the
plasma triglycerides and LPL. This indicates that the magnitude of the
response was similar between LPL and the 18:2 FFA, but not between
LPL and plasma triglycerides [13,30]. In the other previous study,
healthy young men were subjected to an intravenous infusion of a tri-
glyceride emulsion (Intralipid®) at a rate exceeding the normal removal
capacity for triglycerides [13]. In this overload situation, a substantial in-
crease in plasma FFA occurred in some, but not all subjects, and was
closely with a rise in the plasma LPL activity. The study by Saxena et
al. [14] reported that oleic acid dissociated LPL from cultured endotheli-
al cells. The same group studied the effect of different fatty acid (FA)
species on the release of LPL from endothelial cells [34]. Also oral fat
load byOFTT cream showed the similar increase of FFA in Japanese pop-
ulation [18,35]. Furthermore, the mixed meal used in the studies
contained a substantial amount of glucose, which led to postprandial
hyperinsulinemia signiﬁcantly in diabetes patients. However, even
though insulin is strongly antilipolytic [36,37], the total FFA level was
undiminished, which presupposes FFA input into the plasma compart-
ment from sources other than adipose tissue. Nevertheless, insulin
may also exert a direct effect on plasma LPL activity. Eckel et al. [38]
demonstrated that plasma LPL activity increased after an oral glucose
load in the non-heparin plasma of diabetes patients. However, we
were unable to detect any increase in either the LPL activity or concen-
tration after glucose and sucrose load in healthy volunteers as well as in
diabetes patients (data not shown). Cookie test which contained both
fat and carbohydrate did not also show the increase of LPL concentration
after intake associated with the increase of TG-rich lipoproteins
(Table 5).
Beisiegel et al. [39] and others presented data suggesting that LPL
serves as a ligand for the recognition of chylomicron remnants by hepat-
ic receptors. Hence, it may be that LPL is released from its endothelial
binding by high local FFA concentration induced by active lipolysis
and subsequently binds to lipoprotein remnants (RLP-LPL complex)
[33], serving as a ligand that the particles are ready to be taken up by
the liver through the receptors such as LRP1. These results suggested
that an increase of LPL is associated with an increase of remnant lipo-
proteins. However, we recently reported that the amount of LPL present
per RLP particle was inversely correlated with the RLP-TG or RLP-LPL/
RLP-TG ratio (reﬂecting particle size) [26,33]. This means that RLP
with large particle size may be the result of insufﬁcient hydrolysis of
TG-rich lipoproteins by LPL on the endothelium after fat intake.ose treatment (mean ± SD).
e (n = 9) Sucrose (n = 10)
120 min Before 120 m
12.5 191.6 ± 12.8 187.8 ± 37.4 187.6 ± 43.5
35.5 95.3 ± 38.9 120.1 ± 75.6 121.1 ± 77.8
16.7 114.1 ± 16.5 104.9 ± 32.2 105.9 ± 35.3
.1 5.5 ± 3.1 6.3 ± 2.9 6.5 ± 3.9
3.4 18.1 ± 6.4 24.4 ± 16.6 24.6 ± 17.1
.8 12.8 ± 10.3 6.2 ± 2.7 5.6 ± 2.8
22.7 67.1 ± 30.7 69.5 ± 19.5 83.2 ± 17.7
Fig. 5. The changes of plasma LPL concentration at 0, 30, 60, 120min after glucose, sucrose
and water treatment.
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[27] were signiﬁcantly increased in postprandial plasma. This may not
be caused by the increased formation of RLP particles at the endotheli-
um or increased VLDL formation in the liver, but because of insufﬁcient
capacity of LPL hydrolysis activity at endothelium against the
overloaded CM and VLDL exposure after a fat intake. In particular, as
Karpe [9] proposed, LPL hydrolyzes CM more efﬁciently than VLDL
after fat intake, large VLDL remnants rather than CM remnants increase
prevalently in postprandial plasma [7,8]. Therefore, the apoB48particles
in RLP is reportedly smaller than that of the apoB100 particle [40],
which means that apoB48 carrying particles are preferably hydrolyzed
by LPL. Therefore, when the LPL activity is not sufﬁcient to hydrolyze a
large amount of CM or VLDL on endothelium, the RLP particle size be-
comes signiﬁcantly increased along with the high RLP-TG/RLP-C ratio
and less amount of LPL concentration. We reported that RLP particle
size in type 2 diabetes and metabolic syndromewas signiﬁcantly larger
than in controls and was inversely correlated with the circulating LPL
concentration, indicating the pro-atherogenic characteristics of rem-
nants [41]. The delayed clearance of RLP in plasma may largely depend
on the amount of LPL on RLP, which is the ligand for the receptors of
liver and other tissues and organs. However, in case of LPL deﬁciency,
CM and VLDL particles are not metabolized to smaller atherogenic rem-
nants and increase in plasma without cardiovascular disease, but often
causes acute pancreatitis [42].
In sharp contrast to the ﬁndings for LPL, we found that there was no
change in the HTGL activity or concentration between fasting and after
the intake of a standardmeal, althoughHTGLhas been believed to play a
role in remnant metabolism. Peterson et al. [13] reported no change in
HTGL activity after an infusion of lipid emulsions. These ﬁndings indi-
cate that the plasma HTGL remains in a fairly static equilibrium with
the level of HTGL at the vascular binding sites, and that shifts in meta-
bolic conditions do not rapidly change either HTGL activity or its inter-
action with these vascular sites. The experimental conditions used in
the present studymost probably did not result in high local FFA concen-
trations near the HTGL binding site, due to the lipoprotein speciﬁcity of
HTGL,which essentially does not include large TG-rich lipoproteins [38].
In contrast with the previous studies of fat and glucose load [13,30,
38,43–46], we did not detect any signiﬁcant increase in the LPLTable 5
The changes of plasma lipids, lipoproteins, blood sugar and LPL concentration after cookie load
0 h 1 h
TC (mg/dL) 218 ± 63.3 212.7 ± 5
TG (mg/dL) 154.2 ± 139.3 181.0 ± 1
HDL-C (mg/dL) 56.0 ± 13.7 54.4 ± 12
LDL-C (mg/dL) 132.7 ± 57.2 128.7 ± 5
BS (mg/dL) 116.4 ± 22.8 172.8 ± 5
LPL (ng/dL) 69.7 ± 39.9 57.2 ± 19
⁎ p b 0.05.concentration after oral fat and sugar intake. The previous results
weremostly obtained by using a radiochemical LPL activity assaymeth-
od in the non-heparin plasma, which detected a very low LPL activity
level compared with the post-heparin LPL activity level. The LPL activity
assay [22] we used for the non-heparin plasma did not detect any in-
creased LPL activity after a fat and glucose load, unlike shown by Peter-
son et al. [13], Karpe et al. [30] andEckel et al. [38]. Although themethod
we used for the LPL activity assay did not detect LPL activity in the non-
heparin plasma [22,33], the LPL concentration was 50 ng/mL or higher,
which is approximately 1/5 that of the post-heparin LPL concentration.
The LPL activity reported in the non-heparin plasma in previous reports
was b1/100 of the post-heparin LPL activity. This is the other discrepan-
cy between the previous reports and our own results.
Watson et al. [47] subsequently reported an improved radiochemi-
cal method for the selective measurement of post-heparin lipase activ-
ity which was adapted to lipoprotein lipase and hepatic lipase in the
pre-heparin plasma. The assay sensitivity was increased approximately
four-fold by doubling both the volume of the plasma used and the vol-
ume of lipolytic products taken for liquid scintillation counting, and
was further improved by increasing the incubation period by 50% to
90 min. Using the improved assay, it was reported that the pre-heparin
activities of hepatic lipase, but not lipoprotein lipase, appear to be a use-
fulmeasure of the physiological function of “whole body” enzyme activ-
ity in cross-sectional and metabolic studies in which heparinization is
not possible. The pre-heparin LPL activity, may reﬂect displacement of
the enzyme by FFA and the subsequent binding to the remnants of
TG-rich lipoproteins. However, the LPL bound to remnants is known
to be inactive [33], so only a very small portion of the LPL detected in
the non-heparin plasmamay accurately reﬂect the activity. For example
in the previous report [30], LPL activity in patients with myocardial in-
farction (MI) was shown to be signiﬁcantly higher than in the control
group before and after a fat load. However, the recent studies have
shown that the plasma LPL activity and concentration in MI patients
are signiﬁcantly lower in both the non- and post-heparin plasma [28,
29]. Therefore, the LPL activity increased after food intake in previous
reports may reﬂect an increased activity of other lipases in plasma,
using the radiochemical method.
However, as the TG and remnant lipoprotein levels vary greatly
within a day of food intake [48], the LPL concentration in the non-hep-
arin plasma which remains unchanged over a certain period time may
serve as a usefully stable diagnostic marker of TG-rich lipoprotein me-
tabolism that would enable to determine at any time point in either
the fasting or postprandial plasma in diabetes and cardiovascular
patients.
In summary, the present study examined the plasma LPL activity
and concentration using newly developed ELISA in response to an
oral fat and sugar intake in generally healthy subjects covering a
wide range of plasma TG levels. No signiﬁcant increase in the LPL ac-
tivity and concentration took place in parallel with the accumulation
of TG-rich lipoproteins, unlike the ﬁndings previously reported.
Therefore, no increase of LPL activity on endothelium at hydrolysis
after food intake may enhance the formation of large RLP particles
and delayed clearance of RLP associated with small amount of LPL
on RLP as a ligand to receptors.(0 h vs 1 h, 2 h and 4 h by U test) (mean ± SD).
2 h 4 h
8.4 210.0 ± 59.5 214.4 ± 61.9
25.3 233.3 ± 135.3⁎ 240.2 ± 160.5⁎
.4 52.7 ± 12.1 53.0 ± 11.9
3.2 125.3 ± 53.2 127.3 ± 52.9
9.9⁎ 170.7 ± 62.2⁎ 125.5 ± 43.5
.3 61.8 ± 21.4 66.8 ± 28.3
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